Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 104,661,494
- Total 13F shares
- 54,835,912
- Share change
- +2,029,433
- Total reported value
- $1,532,629,456
- Put/Call ratio
- 97%
- Price per share
- $27.95
- Number of holders
- 148
- Value change
- +$56,326,804
- Number of buys
- 72
- Number of sells
- 67
Quarterly Holders Quick Answers
What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 761330109:
Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
5,012,352
|
$142,051,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.1%
|
4,326,053
|
$122,600,000 | — | 31 Dec 2020 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
3.2%
|
3,342,047
|
$94,714,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.1%
|
3,268,117
|
$92,619,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
3,240,171
|
$91,827,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.9%
|
3,065,904
|
$86,888,000 | — | 31 Dec 2020 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.8%
|
2,964,135
|
$84,004,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
2.7%
|
2,852,000
|
$80,826,000 | — | 31 Dec 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
2.6%
|
2,673,313
|
$75,762,000 | — | 31 Dec 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.1%
|
2,201,508
|
$62,391,000 | — | 31 Dec 2020 | |
| Capital World Investors |
13F
|
Company |
2%
|
2,130,000
|
$60,364,000 | — | 31 Dec 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
1,755,863
|
$49,762,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
1,470,276
|
$41,668,000 | — | 31 Dec 2020 | |
| Capital International Investors |
13F
|
Company |
1.1%
|
1,161,900
|
$32,928,000 | — | 31 Dec 2020 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.1%
|
1,154,734
|
$32,725,000 | — | 31 Dec 2020 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
1.1%
|
1,121,152
|
$31,773,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.95%
|
992,094
|
$28,115,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
763,624
|
$21,642,000 | — | 31 Dec 2020 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.71%
|
741,732
|
$21,021,000 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.47%
|
487,436
|
$13,814,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
476,149
|
$13,494,000 | — | 31 Dec 2020 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.41%
|
433,778
|
$12,294,000 | — | 31 Dec 2020 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.41%
|
429,836
|
$12,182,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.41%
|
429,800
|
$12,180,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
411,031
|
$11,649,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
404,126
|
$11,452,000 | — | 31 Dec 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.36%
|
374,676
|
$10,618,318 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
357,922
|
$10,144,000 | — | 31 Dec 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.25%
|
259,694
|
$7,360,000 | — | 31 Dec 2020 | |
| Fosun International Ltd |
13F
|
Company |
0.22%
|
233,841
|
$6,627,000 | — | 31 Dec 2020 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
226,465
|
$6,418,000 | — | 31 Dec 2020 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.21%
|
220,000
|
$6,235,000 | — | 31 Dec 2020 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.2%
|
213,808
|
$6,059,000 | — | 31 Dec 2020 | |
| OSTERWEIS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.17%
|
174,970
|
$4,959,000 | — | 31 Dec 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.15%
|
159,820
|
$4,529,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
151,963
|
$4,308,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
144,063
|
$4,083,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
144,005
|
$4,081,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.13%
|
137,337
|
$3,892,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.13%
|
134,150
|
$3,802,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.1%
|
107,500
|
$3,047,000 | — | 31 Dec 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.1%
|
100,700
|
$2,854,000 | — | 31 Dec 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
95,821
|
$2,716,000 | — | 31 Dec 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
95,261
|
$2,700,000 | — | 31 Dec 2020 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.09%
|
93,820
|
$2,662,000 | — | 31 Dec 2020 | |
| Evolutionary Tree Capital Management, LLC |
13F
|
Company |
0.09%
|
89,348
|
$2,532,000 | — | 31 Dec 2020 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.08%
|
83,091
|
$2,355,000 | — | 31 Dec 2020 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.07%
|
76,671
|
$2,173,000 | — | 31 Dec 2020 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.07%
|
72,700
|
$2,060,000 | — | 31 Dec 2020 | |
| Walleye Capital LLC |
13F
|
Company |
0.07%
|
71,365
|
$2,022,000 | — | 31 Dec 2020 |
Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q1 2021
As of 31 Mar 2021,
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,835,912 shares.
The largest 10 holders included
BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., Palo Alto Investors LP, ArrowMark Colorado Holdings LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Essex Woodlands Management, Inc., and Capital World Investors.
This page lists
148
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
150
Q1 2021 holders
148
Holder diff
-2
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.